Early Rapid Reversal of Platelet Thrombosis With Intravenous Elinogrel Before PCI to Optimize Reperfusion in Acute Myocardial Infarction - ERASE MI


Various studies have demonstrated the utility of the adjunctive use of P2Y12 inhibitors for ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI). The current trial is a phase II trial designed to study the safety and efficacy of escalating doses of intravenous elinogrel, a novel P2Y12 inhibitor, in the treatment of STEMI patients undergoing PPCI.